Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

RecycLiCo Battery Materials Inc. ("RecycLiCo" or the "Company"), , a pioneer in the field of lithium-ion battery recycling technology, is pleased to announce that it has engaged Penney Capital and ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, or semaglutide, has been approved for the treatment of patients with chronic kidney disease and diabetes. Read more here.

Novo Nordisk said on Tuesday the U.S. FDA has approved its blockbuster drug Ozempic to lower the risk of progression of ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

President Donald Trump issued executive orders late Friday reviving some of his first term’s anti-abortion policies, like ...

G/O Media is once again attempting to use AI to churn out content — while simultaneously warning that anything the AI ...

Musk texted Tangen it would be too “difficult and expensive” to travel to Oslo for a home-cooked dinner with other CEOs.

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald ...

Every year, 21.5 million people are forcibly displaced by floods, droughts, wildfires, and storms. This number ...